MYCN expression in human rhabdomyosarcoma cell lines and tumour samples

The Journal of Pathology
Luisa ToffolattiAngelo Rosolen

Abstract

The MYCN oncogene encodes a phosphoprotein that acts as a transcription factor and is involved in the regulation of cell proliferation and differentiation in normal as well as in cancer cells.MYCN amplification and expression have been reported in various tumours, including neuroblastoma and lung cancer, but little is known about its expression in human rhabdomyosarcoma. MYCN expression and amplification were studied in five alveolar and five embryonal rhabdomyosarcoma cell lines and in 19 tumour biopsies. All the cell lines studied expressed MYCN RNA, as demonstrated by northern blot analysis and RT-PCR, but the oncogene was amplified in only one. Similarly, MYCN protein was detected in all cell lines by western blot analysis, with higher levels of expression in alveolar than in embryonal rhabdomyosarcoma cells. RT-PCR analysis of tumour samples demonstrated 18/19 cases positive for MYCN RNA. Although MYCN expression was higher in alveolar than in embryonal rhabdomyosarcoma cell lines, no clear relationship between histology and level of MYCN expression could be established in this tumour series. These data suggest that MYCN expression is a common feature of rhabdomyosarcoma, independent of gene amplification and without a cle...Continue Reading

References

Apr 1, 1992·Molecular and Cellular Biology·R K SmithF W Alt
Apr 15, 1990·International Journal of Cancer. Journal International Du Cancer·P DiasS Kumar
Apr 15, 1990·International Journal of Cancer. Journal International Du Cancer·Y HayashiA M Gown
Dec 21, 1988·Journal of the National Cancer Institute·P D NisenP Lanzkowsky
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J ChellyA Kahn
Jun 1, 1989·British Journal of Cancer·J A GarsonJ T Kemshead
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L W StantonJ M Bishop
Jun 28, 1986·Lancet·J A GarsonJ T Kemshead
Jan 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W A NewtonH Maurer
Jan 1, 1985·Leukemia Research·S V GrahamG D Birnie
Oct 31, 1985·The New England Journal of Medicine·R C SeegerD Hammond
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·M SchwabJ M Bishop
Apr 15, 1994·Cancer·D DrimanJ Squire
Jan 1, 1996·Cytogenetics and Cell Genetics·M MeddebA Bernheim
Jan 4, 1998·Journal of Pediatric Hematology/oncology·F G Barr
Dec 22, 1998·Molecular and Cellular Biology·L E SivakW L Carroll

❮ Previous
Next ❯

Citations

Jun 1, 2005·The Lancet Oncology·Boo MessahelKathy Pritchard-Jones
Oct 7, 2006·Journal of Pediatric Hematology/oncology·Lars M WagnerMary K Danks
Dec 5, 2012·Skeletal Muscle·Amy D Marshall, Gerard C Grosveld
Nov 12, 2009·Future Oncology·Carla De GiovanniPatrizia Nanni
Jul 3, 2013·Proceedings of the National Academy of Sciences of the United States of America·Changxian Shen, Peter J Houghton
Feb 1, 2006·Expert Review of Anticancer Therapy·Daniel A Morgenstern, John Anderson
Jun 23, 2006·Neoplasia : an International Journal for Oncology Research·Myriam GoldsteinAvi Orr-Urtreger
Aug 29, 2006·Seminars in Cancer Biology·Marina Vita, Marie Henriksson
Feb 26, 2013·Expert Opinion on Therapeutic Targets·Mary E Olanich, Frederic G Barr
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel WilliamsonJanet Shipley
Mar 31, 2017·Genes·María Victoria Ruiz-PérezMarie Arsenian-Henriksson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.